Contrafect Corp Stock Price To Sales
ContraFect Corp fundamentals help investors to digest information that contributes to ContraFect Corp's financial success or failures. It also enables traders to predict the movement of ContraFect Stock. The fundamental analysis module provides a way to measure ContraFect Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ContraFect Corp stock.
ContraFect |
ContraFect Corp Company Price To Sales Analysis
ContraFect Corp's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, ContraFect Corp has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
ContraFect Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ContraFect Corp's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ContraFect Corp could also be used in its relative valuation, which is a method of valuing ContraFect Corp by comparing valuation metrics of similar companies.ContraFect Corp is currently under evaluation in price to sales category among its peers.
ContraFect Fundamentals
| Return On Equity | -6.09 | |||
| Return On Asset | -1.17 | |||
| Current Valuation | (2.32 M) | |||
| Shares Outstanding | 10.7 M | |||
| Shares Owned By Insiders | 0.65 % | |||
| Shares Owned By Institutions | 6.13 % | |||
| Number Of Shares Shorted | 115.97 K | |||
| Price To Earning | 21.36 X | |||
| Price To Book | 0.44 X | |||
| Gross Profit | (1.61 M) | |||
| EBITDA | (30.05 M) | |||
| Net Income | (24.14 M) | |||
| Cash And Equivalents | 27.3 M | |||
| Cash Per Share | 0.69 X | |||
| Total Debt | 2.88 M | |||
| Debt To Equity | 0.24 % | |||
| Current Ratio | 1.83 X | |||
| Book Value Per Share | (0.54) X | |||
| Cash Flow From Operations | (35.59 M) | |||
| Short Ratio | 1.18 X | |||
| Earnings Per Share | (10.83) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 23 | |||
| Beta | 0.29 | |||
| Market Capitalization | 535.24 K | |||
| Total Asset | 20.68 M | |||
| Retained Earnings | (325.7 M) | |||
| Working Capital | (3.13 M) | |||
| Current Asset | 34.1 M | |||
| Current Liabilities | 3.77 M | |||
| Z Score | -26.92 | |||
| Net Asset | 20.68 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in ContraFect Stock
If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |